All posts by admin

3 Success tips for Life Science R&D teams: Market Access, Part 1

Show value from harmonized product development data  Using harmonized data from clinical trials and other relevant data sources, R&D teams can define patient populations that respond best to the product, aiding commercial prospects. Data insights derived during product development can influence commercial strategy such as

Data Partnerships crucial for Data Moat

Before a deep dive into data partnerships, it is imperative to define product strategy, user story, use cases and the competitive advantage aka the data moat.  While data is not the new oil, the right data strategy is critical for health and life sciences ML/AI

Data privacy tradeoffs for AI in Life Sciences

Covid -19 has changed the data privacy paradigm. What used to be controversial with regards to accessing and mining large data sets with Business Associate Agreements (BAA), due to ensuing consumer privacy backlash is beginning to become more acceptable. While we are still at baby

Google and Fitbit: A Data Play?

We learned not long ago that Google is acquiring Fitbit. It’s easy to see why. Data and users may sound like the main consideration for this deal, but there is more at play.  Hardware meets software Over the last several years, Google has shown its

The NHS, a hot bed for Innovation in Life Sciences

Much is talked about health care distribution channels such as payers here in the US. Yet just across the atlantic, there is a payer that is just as important especially when it comes to testing AI in life sciences – the UK National Health Service

Digital Health IPOs in 2019

Livongo and Health Catalyst made the public markets late last month, showcasing how the market in terms of VC and customer acquisition for B2B healthcare and the wider tech industry will likely adapt. On the surface both companies may look like healthcare companies but on

Examples of Integrated B2B Marketing in Digital Health

Digital health investments continues to grow. Funding reached an impressive $8.1B in 2018, an increase of 42% from 2017 according to a Rock Health year end report with average deal size at $21.9M. While that is the case, what is particularly interesting is the new